Effects of probiotics (cultured Lactobacillus subtilis/ Streptococcus faecium) in the treatment of alcoholic hepatitis: Randomized-controlled multicenter study

European Journal of Gastroenterology and Hepatology

Volumn 27, Issue 11, 2015, Pages 1300-1306

  Han, Sang Hak ^a   Suk, Ki Tae ^a   Kim, Dong Joon ^a   Kim, Moon Young ^d   Baik, Soon Koo ^d   Kim, Young Don ^e   Cheon, Gab Jin ^e   Choi, Dae Hee ^c   Ham, Young Lim ^f   Shin, Dong Hoon ^a   Kim, Eun Ji ^b  

^a Hallym University College of Medicine   (South Korea)

^b Hallym University   (South Korea)

^c Kangwon National University College of Medicine   (South Korea)

^d Yonsei University Wonju College of Medicine   (South Korea)

^e University of Ulsan College of Medicine   (South Korea)

^f Daewon University   (South Korea)

Author keywords

Alcoholic; Cytokines; Hepatitis; Lipopolysaccharides; Probiotics

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; LIPOPOLYSACCHARIDE; PLACEBO; PROBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA; SERUM ALBUMIN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALCOHOL LIVER DISEASE; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BACTERIUM CULTURE; BILIRUBIN BLOOD LEVEL; COLONY FORMING UNIT; CONTROLLED STUDY; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; FECES CULTURE; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; LACTOBACILLUS; LACTOBACILLUS SUBTILIS; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL; THERAPY EFFECT; BACTERIAL COUNT; BLOOD; CLINICAL TRIAL; FECES; HEPATITIS, ALCOHOLIC; INTESTINE FLORA; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY;

ADULT; ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; COLONY COUNT, MICROBIAL; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; FECES; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; GASTROINTESTINAL MICROBIOME; HEPATITIS, ALCOHOLIC; HUMANS; LACTOBACILLUS; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; PROBIOTICS; PROTHROMBIN TIME; SERUM ALBUMIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84942791105     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0000000000000458     Document Type: Article

References (31)

1. Kim WR, Brown RS Jr, Terrault NA, El-Serag H. Burden of liver disease in the United States: summary of a workshop. Hepatology 2002; 36:227-242.
2. Lucey MR, Mathurin P, Morgan TR. Alcoholic hepatitis. N Engl J Med 2009; 360:2758-2769.
3. Naveau S, Giraud V, Borotto E, Aubert A, Capron F, Chaput JC. Excess weight risk factor for alcoholic liver disease. Hepatology 1997; 25:108-111.
4. Chassaing B, Etienne-Mesmin L, Gewirtz AT. Microbiota-liver axis in hepatic disease. Hepatology 2014; 59:328-339.
5. Suez J, Korem T, Zeevi D, Zilberman-Schapira G, Thaiss CA, Maza O, et al. Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature 2014; 514:181-186.
6. Cox AJ, West NP, Cripps AW. Obesity, inflammation, and the gut microbiota. Lancet Diabetes Endocrinol 2015; 3:207-215.
7. Szabo G, Bala S. Alcoholic liver disease and the gut-liver axis. World J Gastroenterol 2010; 16:1321-1329.
8. Mandrekar P, Bala S, Catalano D, Kodys K, Szabo G. The opposite effects of acute and chronic alcohol on lipopolysaccharide-induced inflammation are linked to IRAK-M in human monocytes. J Immunol 2009; 183:1320-1327.
9. Liu Q, Duan ZP, Ha DK, Bengmark S, Kurtovic J, Riordan SM. Symbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology 2004; 39:1441-1449.
10. Kirpich IA, Solovieva NV, Leikhter SN, Shidakova NA, Lebedeva OV, Sidorov PI, et al. Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: A pilot study. Alcohol 2008; 42:675-682.
11. Seo YS, Shah VH. The role of gut-liver axis in the pathogenesis of liver cirrhosis and portal hypertension. Clin Mol Hepatol 2012; 18:337-346.
12. Stadlbauer V, Mookerjee RP, Hodges S, Wright GA, Davies NA, Jalan R. Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis. J Hepatol 2008; 48:945-951.
13. Gabbard SL, Lacy BE, Levine GM, Crowell MD. The impact of alcohol consumption and cholecystectomy on small intestinal bacterial overgrowth. Dig Dis Sci 2014; 59:638-644.
14. Szabo G, Bala S, Petrasek J, Gattu A. Gut-liver axis and sensing microbes. Dig Dis 2010; 28:737-744.
15. Steed H, Macfarlane GT, Blackett KL, Macfarlane S, Miller MH, Bahrami B, et al. Bacterial translocation in cirrhosis is not caused by an abnormal small bowel gut microbiota. FEMS Immunol Med Microbiol 2011; 63:346-354.
16. Wang H, Zhang W, Zuo L, Zhu W, Wang B, Li Q, Li J. Bifidobacteria may be beneficial to intestinal microbiota and reduction of bacterial translocation in mice following ischaemia and reperfusion injury. Br J Nutr 2013; 109:1990-1998.
17. Di Bella S, Drapeau C, García-Almodóvar E, Petrosillo N. Fecal microbiota transplantation: The state of the art. Infect Dis Rep 2013; 5: e13.
18. Cammarota G, Ianiro G, Bibbo S, Gasbarrini A. Gut microbiota modulation: probiotics, antibiotics or fecal microbiota transplantation? Intern Emerg Med 2014; 9:365-373.
19. Borowsky SA, Strome S, Lott E. Continued heavy drinking and survival in alcoholic cirrhotics. Gastroenterology 1981; 80:1405-1409.
20. Pessione F, Ramond MJ, Peters L, Pham BN, Batel P, Rueff B, Valla DC. Five-year survival predictive factors in patients with excessive alcohol intake and cirrhosis. Effect of alcoholic hepatitis, smoking and abstinence. Liver Int 2003; 23:45-53.
21. Ho AM, Contardi LH, Ho AM, Contardi LH, Teli MR, Day CP, et al. Pure alcoholic fatty liver and progression to cirrhosis or fibrosis. Lancet 1995; 346:1562-1563.
22. Forsyth CB, Farhadi A, Jakate SM, Tang Y, Shaikh M, Keshavarzian A. Lactobacillus GG treatment ameliorates alcohol-induced intestinal oxidative stress, gut leakiness, and liver injury in a rat model of alcoholic steatohepatitis. Alcohol 2009; 43:163-172.
23. Wiest R, Lawson M, Geuking M. Pathological bacterial translocation in liver cirrhosis. J Hepatol 2014; 60:197-209.
24. Ma YY, Li L, Yu CH, Shen Z, Chen LH, Li YM. Effects of probiotics on nonalcoholic fatty liver disease: A meta-analysis. World J Gastroenterol 2013; 19:6911-6918.
25. Mutlu E, Keshavarzian A, Engen P, Forsyth CB, Sikaroodi M, Gillevet P. Intestinal dysbiosis: A possible mechanism of alcohol-induced endotoxemia and alcoholic steatohepatitis in rats. Alcohol Clin Exp Res 2009; 33:1836-1846.
26. Nanji AA, Khettry U, Sadrzadeh SM. Lactobacillus feeding reduces endotoxemia and severity of experimental alcoholic liver (disease). Proc Soc Exp Biol Med 1994; 205:243-247.
27. Zhao HY, Wang HJ, Lu Z, Xu SZ. Intestinal microflora in patients with liver cirrhosis. Chin J Dig Dis 2004; 5:64-67.
28. Stickel F, Hoehn B, Schuppan D, Seitz HK. Review article: Nutritional therapy in alcoholic liver disease. Aliment Pharmacol Ther 2003; 18:357-373.
29. Henkel AS, Buchman AL. Nutritional support in patients with chronic liver disease. Nat Clin Pract Gastroenterol Hepatol 2006; 3: 202-209.
30. Campillo B, Richardet JP, Scherman E, Bories PN. Evaluation of nutritional practice in hospitalized cirrhotic patients: results of a prospective study. Nutrition 2003; 19:515-521.
31. Firmesse O, Mogenet A, Bresson JL, Corthier G, Furet JP. Lactobacillus rhamnosus R11 consumed in a food supplement survived human digestive transit without modifying microbiota equilibrium as assessed by real-time polymerase chain reaction. J Mol Microbiol Biotechnol 2008; 14:90-99.